Get started
Author

Oğuzhan Selvi

Observed names: O. Selvi, Oguzhan Selvi, Oğuzhan SELVİ
Observed institutions: Eskişehir City Hospital, Istanbul University-Cerrahpaşa, Sağlık Bilimleri Üniversitesi, Bezmiâlem Vakıf Üniversitesi Hastanesi, Okmeydanı Eğitim ve Araştırma Hastanesi, Istanbul University
ORCID: 0000-0003-4465-1107
Observed ORCIDs: 0000-0003-4465-1107, 0000-0003-1470-6242
OpenAlex ID: A5054602049
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever
2020 · Serdal Ugurlu, Bilgesu Ergezen, et al. · Rheumatology · 36
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
2020 · Serdal Ugurlu, Bilgesu Ergezen, et al. · Rheumatology · 25
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24
PDF
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
2022 · Yusuf Ilhan, Ali Murat Tatli, et al. · International Journal of Gynecological Cancer · 13
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023 · Çağlar Ünal, Abdulmunir Azizy, et al. · The Oncologist · 11
PDF
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
2024 · Mehmet Fatih Ozbay, Hakan Harputluoglu, et al. · Cancers · 10
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
2023 · Arif Akyildiz, Deniz Can Guven, et al. · Medicine · 9
Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer
2021 · Muhammed Mustafa Atci, Abdullah Sakin, et al. · Journal of College of Physicians And Surgeons Pakistan · 8
PDF
Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
2021 · Savaş Karyağar, Osman Güven, et al. · Nuclear Medicine Communications · 8
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study
2022 · Muhammed Mustafa Atci, Baran Akagunduz, et al. · Oncology Research and Treatment · 6
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024 · İsmail Beypınar, Hacer Demir, et al. · Breast Cancer Research and Treatment · 5
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 5
PDF
A new biomarker for lung metastasis in non-seminomatous testicular cancer: De Ritis Ratio
2022 · Muammer Bozkurt, Samir Aghalarov, et al. · Aktuelle Urologie · 4
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome
2024 · Muhammed M. Atci, Saban Secmeler, et al. · Indian Journal of Cancer · 3
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients
2024 · Mert Erciyestepe, Oğuzhan Selvi, et al. · Oncology · 3
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
2022 · Özgecan Dülgar, Başak Bala Öven, et al. · Expert Review of Anticancer Therapy · 3
Modulation of sphingolipid metabolism: Investigation of the apoptotic and cytotoxic effects of the ceramidase Inhibitor D-e-MAPP in HT29 colon cancer cells
2025 · Hüseyin İzgördü, Oğuzhan Selvi, et al. · Biological Diversity and Conservation · 2
PDF
The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data
2023 · Sabin Goktas Aydin, Omer Fatih Olmez, et al. · Journal of Gastrointestinal Cancer · 1
Sat0518 Canakinumab Treatment in Adult Patients With Familial Mediterranean Fever: a Single-center Study
2020 · S. Ugurlu, B.H. Egeli, et al. · Annals of the Rheumatic Diseases · 1
Impact of SAA versus CRP in evaluation of acute-phase response in familial Mediterranean fever: A prospective study
2026 · Oguzhan Selvi, Bugra Han Egeli, et al. · Medicine
Dynamic increase in FIB-4 during treatment is associated with worse overall survival in metastatic colorectal cancer
2026 · Harun Avcuoglu, Sabin Goktas Aydın, et al. · Research Square
PDF
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study
2026 · Osman Sütcüoğlu, Orhun Akdoğan, et al. · Discover Oncology
Ab1470 Does Testing for Saa Is More Beneficial Than Crp for the Follow-up of Patients With Fmf?
2022 · M. Oztas, O. Selvi, et al. · Annals of the Rheumatic Diseases
PDF
Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study
2022 · Muhammed Mustafa ATCI, Orçun CAN, et al. · Journal of Oncological Sciences
PDF
COVID-19 ve Kanser
2021 · Sevilay Süreyya Ermiş, Müge Ayhan, et al. · Akademisyen Kitabevi eBooks
Works count: 28
Citation count: 172
H-index: 8
I10-index: 5
Year
Topic
Type